# VisionScan AI Eye Center — Full System Report

**Report date:** 2026-09-12  
**System:** VisionScan AI Eye Center (eye-ai-platform 0.1.0)  
**Repository:** D:/AI EYE ANALYSIS PLATFORM  
**Audited revision:** main at 3c702f2 (docs: record final report CI)  
**Audience:** engineering, research, safety, security, and release review

## 1. Executive conclusion

VisionScan is a substantial, locally runnable ophthalmic research platform with a coherent end-to-end workflow: authenticated user access, patient/study/encounter records, immutable image and document ingestion, modality routing, quality gates, research-model inference, document extraction, evidence synthesis, triage, report generation, clinician review, longitudinal/cross-modality comparison, and validation tooling.

The current checkout passed the fresh local engineering verification performed for this report:

- lint and TypeScript checking passed;
- the full Vitest suite passed with **997 passed, 10 skipped** across **69 passed and 1 skipped test files**;
- the production build passed and generated all **21/21 static pages**;
- the isolated API smoke workflow passed **16/16**;
- browser hosted smoke passed **6/6**;
- serial responsive, accessibility, and keyboard browser gates passed **80/80**, **20/20**, and **21/21**;
- model-enabled browser asset end-to-end testing passed for fundus research analysis and mixed PDF/OCT routing;
- model manifest audit, filesystem audit, SQLite integrity checks, foreign-key preflight, and reconciliation adjudication completed successfully.

That engineering result must not be read as clinical readiness. The system remains explicitly:

> **NOT VALIDATED — NOT A MEDICAL DEVICE — NOT FOR CLINICAL USE**

The installed model artifacts are registered as RESEARCH, not clinically validated. They have no deployment-specific calibration or clinical validation, and the diagnosis gate is designed to remain closed. The application may produce research observations and urgency-oriented triage, but it must not be used as an autonomous diagnostic, treatment, or patient-management system.

The most material release blockers are:

1. **Clinical boundary:** no clinically validated model, no deployment calibration, no validated device scope, and no diagnosis authorization.
2. **Data release integrity:** the current release-data check reports **235 active unresolved source-artifact blockers** and **75 legacy unresolved records**; the local database also contains **5,263 classified legacy detached references** requiring reconciliation before a clean data release.
3. **Privacy/security operations:** consent recording exists, but the hard-gate helper has no production call site; TLS, disk encryption, MFA, shared rate limiting, formal retention/deletion scheduling, and a full data-subject export workflow remain deployment responsibilities or gaps.
4. **Scale/operations:** the durable queue and lease logic are present, but execution is currently in-process and single-node; an external worker/control-plane design is still needed for production-scale operation.
5. **Documentation currency:** several historical documents still describe an empty model directory or JSON-first storage, while the current source contains three installed research models and SQLite persistence. The report is the current-state snapshot; those documents should be reconciled.

## 2. Scope and evidence basis

This report describes the current source checkout and local data/configuration observed on 2026-09-12. It is an engineering and safety assessment, not a regulatory submission, clinical validation study, penetration test, or independent audit.

Evidence was taken from:

- the current TypeScript/Next.js source and package configuration;
- model manifests and local model artifacts;
- current test, build, lint, typecheck, audit, smoke, browser, model, filesystem, database, and release scripts;
- isolated local smoke runs using dedicated test storage;
- current SQLite integrity and reconciliation checks;
- current CI workflow definitions;
- existing generated release evidence, clearly labeled where it was not regenerated or where it is stale.

No patient identifiers, authentication secrets, or environment-file contents are reproduced in this report. The local data/ tree contains persistent application records and should be treated as sensitive unless independently de-identified.

## 3. System identity and intended role

VisionScan is a Next.js/React application for structured ophthalmic image and record research. Its intended current role is to help researchers and clinicians review source material, test model behavior, organize evidence, and inspect research-only outputs with explicit provenance and uncertainty.

The application is not currently authorized to:

- diagnose a patient;
- establish normality from a negative or out-of-distribution image;
- recommend, prescribe, start, stop, or change medication;
- replace clinician interpretation;
- claim performance beyond the evidence and validation state of a registered model;
- silently infer progression, causation, treatment response, or disease absence.

The current design distinguishes patient context, document-derived candidate information, model observations, possible conditions, treatment information, clinician corrections, and final clinician sign-off.

## 4. Current technology and deployment profile

| Area | Current implementation |
|---|---|
| Web runtime | Next.js 16.3.4 with React 18.3.1 and TypeScript |
| Server/runtime | Node.js 20.20.2; Python 3.12.10 available for local model providers |
| UI | React pages and reusable shell/viewer/evidence/research components |
| Persistence | SQLite via better-sqlite3, schema version 1, migration version 1, WAL mode |
| Legacy persistence | JSON is retained only for explicit migration/compatibility paths |
| Imaging | Byte-level classification, Sharp-based image checks, modality routing, source hashing |
| Documents | PDF page routing, text-layer extraction, bounded OCR with Tesseract, clinical candidate extraction |
| Models | Local research providers for fundus DR grading, fundus lesion localization, and OCT classification |
| Research | Dataset management, locked/read-only test sets, adjudication, validation registry, metrics, model transitions |
| Queue | SQLite-backed durable jobs with leases, heartbeats, retries, cancellation, and fencing |
| Security | Server-side sessions, RBAC, CSRF protection, scope checks, password hashing, audit-oriented records |
| Build/deploy shape | Local/self-hosted web application; CI workflows for Ubuntu, Windows, and browser verification |
| Default posture | DEMO_MODE=true unless configured otherwise; production use remains prohibited |

The source inventory contains approximately **80 app files**, **146 library files**, **9 shared component files**, **73 test files**, and **35 script files**. The current app exposes **19 page routes** and **58 API route handlers**.

## 5. User-facing workflow

The principal workflow is:

1. Authenticate through the login/session flow.
2. Create or select a patient, encounter, and study within the permitted scope.
3. Upload an image or document.
4. Persist the original bytes immutably and calculate a source hash.
5. Classify and route the asset by content and modality.
6. Apply quality, integrity, and ambiguity gates.
7. Run a registered model only when its status and modality/device constraints allow research execution.
8. Store model observations with provenance, model version, source hash, and uncertainty/limitation language.
9. Extract bounded document text and structured candidate findings when documents are present.
10. Synthesize evidence from symptoms, records, documents, and model observations.
11. Apply triage ordering, with red-flag symptoms and quality failures taking priority.
12. Generate a provenance-linked report or research result.
13. Allow clinician/reviewer actions and corrections to remain distinct from the original AI output.
14. Support comparison, replay, validation, and research export workflows subject to the available evidence and access scope.

The current UI includes landing/login, dashboard, patients, analysis, processing, result, history, comparison, report, clinician review, settings, devices, models, evaluations, validation, and administrative views.

## 6. Architecture and processing pipeline

The core design can be summarized as:

    Upload
      -> immutable original bytes + SHA-256 provenance
      -> content/modality classifier and safe router
      -> quality and integrity gates
      -> model registry/status/device gate
      -> research-only model observation
      -> uncertainty and out-of-distribution handling
      -> evidence synthesis from patient context and documents
      -> symptom/red-flag-aware triage
      -> report, reviewer correction, clinician finalization, and audit trail

Documents follow a parallel path:

    PDF
      -> page-level classification
      -> text layer first, bounded OCR fallback
      -> source page/ROI/hash provenance
      -> unreviewed document candidates
      -> clinician confirmation or evidence synthesis

Cross-modality and longitudinal features compare explicit observations and source dates. They are designed to describe observed differences and missingness rather than assert disease progression, causality, or treatment response without appropriate evidence.

### 6.1 Ingestion and routing

The asset router supports image, PDF, DICOM, and unsupported/other container categories and recognizes fundus, OCT, OCTA, FAF, FA, ICG, slit-lamp, and unknown modalities. It:

- recomputes classification from immutable bytes in the analysis path;
- compares declared and observed content;
- rejects unsupported or ambiguous cases safely;
- routes PDF pages individually;
- preserves source hash and page/ROI identity;
- avoids trusting filenames or client-declared modality.

DICOM is recognized as a container category but is not presented as a fully integrated clinical DICOM workflow. Unsupported or ambiguous input is intended to fail closed.

### 6.2 Quality and out-of-distribution handling

The pipeline applies quality checks before interpreting model output. The safety layer includes:

- quality failure handling;
- bounded confidence/uncertainty checks;
- synthetic/demo-label detection;
- forbidden diagnostic-claim scanning;
- provenance and timestamp requirements;
- negative-result caveats;
- calibration honesty;
- an out-of-distribution normality ban;
- model validation-status checks.

In the no-model isolated smoke run, a clean synthetic image was correctly surfaced as inconclusive/out-of-distribution rather than treated as a normal clinical result.

### 6.3 Model execution

The local provider interface supports a demo provider and real local providers. Real providers:

- verify artifact hashes;
- invoke Python/ONNX/SafeTensors implementations through bounded subprocesses;
- enforce strict raw-output contracts;
- use a serialized execution mutex;
- apply a process-local cache keyed by study/source/model/version/preprocessing/eye/ROI;
- do not silently fall back to synthetic output when a real provider fails.

The current real-model execution is research inference. It is not a validated clinical inference service.

### 6.4 Evidence and clinical reasoning

Evidence synthesis keeps separate source types for symptoms, patient history, medications, allergies, document candidates, AI findings, and conditions. It preserves:

- source identity and provenance;
- laterality;
- assertion status and explicit negation;
- conflicts and missingness;
- clinician verification state;
- temporal relationships.

Specialist and consensus structures are available for research orchestration. Treatment-related output is gated behind validated conditions and a medication registry; the current installed research models have no supported conditions, so they do not authorize treatment.

### 6.5 Reports and review

Report generation uses model registry state, provenance, evidence references, and reasoning snapshots. The system supports:

- immutable reasoning snapshot/version freeze;
- report and source hashes;
- report supersession;
- admin-only legacy replay behavior;
- separation of AI-generated content from clinician review;
- explicit clinician finalization rather than automatic signature.

The report layer is an auditability mechanism, not proof that the underlying model is clinically correct.

### 6.6 Durable jobs

The queue implements durable SQLite job records, stages, heartbeats, leases, retry/cancellation behavior, attempt identifiers, compare-and-swap/fencing safeguards, and stale-job recovery. A failed job is not supposed to yield a successful result.

The current operational limitation is that execution is in-process. Horizontal scale, independent workers, queue isolation, distributed locking, and production observability are not yet demonstrated.

## 7. Installed model inventory

All installed model manifests audited successfully. All three are marked validation_status=research_only, with no patient data in the model packages.

| Model | Modality/output | Current status | Material limitation |
|---|---|---|---|
| fundus-dr-grading-effb0 | Fundus DR grade estimate, grades 0–4 | RESEARCH | No deployment calibration or clinical validation; output is an observation-level grade, not a diagnosis |
| fundus-lesions-clementp-unet-seresnext50 | Fundus lesion localization | RESEARCH | Research localization only; no clinical validation or device compatibility; no established clinical overlay/segmentation claim |
| oct-retinal-weights-fp32 | OCT class estimate: CNV/DME/DRUSEN/NORMAL | RESEARCH | CPU classifier research output; no clinical validation, calibration, or confirmed device compatibility; no clinical normality claim |

The registry also includes explicit status capability rules for demo, research, internal validation, external validation, clinical validation, and retired states. The current diagnosis gate requires CLINICALLY_VALIDATED status plus intended-use evidence, modality/quality eligibility, calibration, and sufficient evidence. With the current registry, that gate remains closed.

Technical evaluation assets exist for selected research models and datasets, including external/evaluation records for DeepDRiD-, Duke OCT-, Kermany-, APTOS-, and IDRiD-related work. Those records do not convert the installed artifacts into clinically validated models for this deployment.

## 8. Document intelligence

The document service is designed for clinical-document research rather than authoritative chart abstraction. It:

- verifies the original document hash before extraction;
- prefers embedded text and falls back to scanned-page OCR;
- bounds characters, pages, OCR time, and render dimensions;
- tracks VALID, PROCESSING, READY, and FAILED states;
- clears stale extraction results during retry;
- stores extracted artifacts separately from originals;
- preserves document, page, ROI, and source hashes;
- marks extracted clinical candidates as unreviewed;
- keeps explicit negations separate from positive candidates;
- allows additive clinician annotations.

PDF intelligence includes page content typing for OCT B-scans, thickness maps, and related material, with modality/laterality handling. Ambiguous laterality such as combined OD/OS text remains unknown/ambiguous rather than being silently assigned. Measurement normalization requires units; raw values are preserved and unitless normalized values remain null.

The model-enabled browser E2E run verified a mixed-PDF flow with **3 routed pages** and **8 OCT ROIs**, plus research provenance in the resulting view.

## 9. Clinical-safety controls and boundaries

### Controls present

- Research-only status on installed model manifests.
- Closed diagnosis gate for non-clinically validated models.
- Fail-closed behavior for unsupported, conflicting, corrupt, or ambiguous inputs.
- Quality checks before interpretation.
- Out-of-distribution handling that prohibits normality claims.
- Red-flag symptom triage prioritized above model reassurance.
- AI cannot downgrade a higher-urgency safety state.
- Provenance-linked observations and source hashes.
- Unreviewed status for document-extracted candidates.
- Explicit clinician review/finalization separation.
- Negative-result caveats and uncertainty language.
- No automatic prescription or medication instruction.
- No synthetic fallback after a real model execution failure.
- Claim scanning for forbidden diagnostic or validation language.
- Longitudinal comparison phrased as observed difference rather than automatic progression.

### Important limitations

- No installed model has deployment-specific clinical validation or calibration.
- Device, acquisition protocol, population, and intended-use compatibility are not clinically established.
- Research model scores and grades are not diagnoses and must not be displayed or interpreted as such.
- A clean, unsupported, or out-of-distribution image cannot establish normality.
- The lesion provider is not evidence of a clinically validated segmentation/overlay system.
- DICOM and clinical interoperability are incomplete.
- Specialist/condition/treatment pathways are guarded and do not become valid merely because the UI can display them.

## 10. Medication and treatment safety

The medication knowledge registry is intentionally empty because no licensed drug/formulary or guideline source is connected. The code correctly refuses to invent records from model or language-model memory.

The system can preserve raw medication observations from encounters or documents and can return unresolved/unknown semantics. It does not establish that a medication is safe simply because no text match was found. It does not issue prescriptions, orders, or automatic medication changes.

Before any treatment-support feature could be considered, the deployment would need a jurisdiction-specific, citable medication source; versioning and update governance; patient-factor completeness; allergy, contraindication, and interaction coverage; clinical validation; and clinician-controlled authorization.

## 11. Identity, access, and authorization

The current auth/RBAC design includes:

- roles ADMIN, CLINICIAN, REVIEWER, RESEARCHER, and TECHNICIAN;
- server-side authorization on protected API routes;
- tenant/patient/study scope checks and active access grants;
- scrypt password hashing with random salt and a 64-byte derived key;
- password policy and account lockout after repeated failures;
- opaque session tokens stored only as hashes;
- sliding and absolute session expiry;
- double-submit CSRF protection;
- production secure-cookie expectations;
- admin-controlled reset flow without an email-reset dependency;
- session-derived reviewer identity;
- role and scope tests.

The page proxy provides UX gating, but API handlers are the security boundary and perform the substantive session/role/scope checks. Local smoke/browser verification used ALLOW_INSECURE_LOCAL_AUTH=true only in isolated test servers; that setting must not be carried into a production deployment.

The consent API and records exist for study-level consent purposes. However, requireGrantedConsent() is currently defined as an available helper and has no production call site in lib/ or app/. Consent is therefore not yet a universal hard gate on analysis or all downstream processing.

## 12. Privacy, data governance, and operational security

### Implemented or partially implemented

- Original and derived asset separation.
- Source hashing and integrity checks.
- Scoped deletion workflow.
- Audit-oriented records and event structures.
- Consent record/withdrawal endpoints.
- Dataset-level de-identification keys and split-leakage safeguards for research workflows.
- Encrypted backup evidence is recorded in the release inventory.
- Application data is configured under the D: project/data roots in this environment.

### Not demonstrated or not yet complete

- TLS termination and certificate management are external deployment responsibilities.
- Disk encryption and secrets management are external deployment responsibilities.
- MFA is not implemented.
- Login rate limiting is in-memory and not shared across instances.
- Automatic retention scheduling and legal-hold-aware deletion are not established.
- A dedicated bulk export/data-subject-rights workflow is not established.
- Consent is not a universal analysis hard gate.
- DICOM de-identification and FHIR integration are not complete.
- External worker isolation and production monitoring are not complete.

The filesystem audit found project/source/data storage on D: with approximately **392.2 GB free**. Node/npm and Windows temp/cache dependencies remain on C:, which is expected for this workstation and should be considered in deployment/storage policy.

## 13. Persistence and current local data snapshot

The active local persistence layer is SQLite. Read-only checks reported:

- database integrity: ok;
- foreign keys: enabled;
- journal mode: wal;
- busy timeout: 5,000 ms;
- schema version: 1;
- migration version: 1.

Selected current row counts:

| Domain | Counts |
|---|---:|
| Users / patients / encounters | 461 / 321 / 109 |
| Studies / documents / analyses | 460 / 5,577 / 98 |
| Evidence / reasoning records / reports | 111 / 122 / 104 |
| Jobs / sessions / access grants / consent | 12 / 4,846 / 43 / 109 |
| Test results / comparisons / evaluation runs | 417 / 31 / 110 |
| Datasets / dataset samples / adjudications | 776 / 501 / 232 |
| Transitions / calibration records / record extractions | 568 / 284 / 1,972 |
| Reconciliation journal entries | 89 |

Several relational production-oriented collections are currently empty in this local snapshot, including model_executions, condition_assessments, specialist_packages, clinician_reviews, audit_events, validation_cases, model_registry_state, and devices. This is a data-state observation, not a claim that the corresponding code paths do not exist.

### 13.1 Release-data reconciliation

The current reconciliation adjudication found **310 total records**:

- **235** MISSING_REQUIRED_ARTIFACT;
- **75** VALID_LEGACY_STATE.

The current release-data check reports:

- active unresolved sources: **235**;
- legacy unresolved sources: **75**;
- active foreign-key orphan count: **0**;
- legacy detached-reference count: **5,263**;
- cross-tenant reference count: **0**;
- source-hash mismatch count: **0**;
- quarantine count: **81**;
- active data-release-safe: **false**;
- overall status: BLOCKERS_REMAIN.

This means the current code/test build can be green while the current local data inventory is not ready for an unrestricted release. The 5,263 legacy references are classified legacy/detached references rather than proof that all are live-data corruption, but they still require an explicit reconciliation decision, archival policy, or migration closure.

### 13.2 Backup evidence

The current release-inventory command reports a verified backup available at data/backups/backup-release-20260910143502, with 9,968 assets and no credentials included. This report did not perform a new restore cycle; restore status should therefore be treated as recorded evidence pending a release-time restore verification.

## 14. Verification results

The following results are from the current audit window unless explicitly labeled as recorded/generated evidence.

| Check | Result | Interpretation |
|---|---|---|
| npm run lint | PASS, exit 0 | Source lint clean |
| npx tsc --noEmit --pretty false | PASS, exit 0 | TypeScript check clean |
| npx vitest run --pool=forks --maxWorkers=1 --minWorkers=1 | PASS, exit 0 | 69 files passed, 1 skipped; 997 tests passed, 10 skipped |
| npm run build | PASS, exit 0 | Next webpack build; 21/21 static pages generated |
| npm audit --omit=dev --audit-level=high --json | PASS, exit 0 | No production high/critical vulnerabilities reported |
| npm audit --json | NON-GREEN, exit 1 | Two moderate dev-tool advisories for Vitest / @vitest/mocker; upgrade path is a major Vitest release |
| npm run model:audit | PASS | Three manifests; no patient data; all research-only |
| npm run audit:fs | PASS | Project/source/data roots on D; expected C: dependency/cache exceptions |
| npm run smoke | PASS, 16/16 | Auth, upload, analysis, triage, report, review, deletion, and authorization flow |
| npm run browser:ci hosted smoke | PASS, 6/6 | Authenticated hosted browser smoke |
| npm run browser:responsive | PASS, 80/80 | Ten routes across eight viewport widths |
| npm run browser:a11y | PASS, 20/20 | Ten routes at mobile and desktop widths |
| npm run browser:keyboard | PASS, 21/21 | Serial keyboard/focus/drawer navigation gate |
| npm run browser:asset-e2e | PASS | Real research model asset flow plus mixed PDF/OCT routing |
| node scripts/fk-preflight.mjs | PASS, exit 0 | Foreign-key preflight itself completed without a fatal error |
| npx vite-node scripts/reconciliation-adjudicate.ts | PASS, exit 0 | Reconciliation report generated; blockers remain in data |
| npm run release:data-check | EXPECTED BLOCKED, exit 1 | Correctly reports BLOCKERS_REMAIN for current data |
| npm run release:inventory | PASS | Current source/model/environment inventory emitted |

The Vitest suite includes real CPU model tests. Ten tests were skipped, including the optional Python bridge cases whose candidate environment/artifact is not ready; skipped tests are not counted as passing coverage.

The legacy npm run visual-qa script was not used as the authoritative result for this report. A release-quality visual check should run through the authenticated browser harness or be updated so protected routes are exercised with a valid session.

## 15. CI and release automation

The repository CI workflow defines:

- Ubuntu verification with dependency install, database initialization, typecheck, single-worker tests, migration/backup dry runs, persistence benchmark, validation cases, model audit, SBOM, release inventory, filesystem audit, and build.
- Windows verification with Windows path/safety tests plus the main verification gates.
- Browser verification with isolated storage, a temporary local server, Chromium installation, and browser smoke.

The local audit does not assert the current online GitHub run status. The release-inventory command was run without CI environment identifiers, so its current emitted ci_run_ids list was empty.

## 16. Known gaps and release risk register

| Priority | Gap | Why it matters | Required disposition |
|---|---|---|---|
| P0 | Models are research-only | Clinical use would exceed validation evidence and intended-use controls | Keep clinical use disabled; complete independent clinical validation, calibration, device/population validation, and governance before reconsideration |
| P0 | Diagnosis gate remains closed | No model currently qualifies for diagnosis | Preserve the gate; do not add label/normality workarounds |
| P1 | 235 active unresolved source artifacts | Current data release is not safe by the data check | Resolve, quarantine, or formally archive each item with evidence |
| P1 | 5,263 legacy detached references | Migration/reconciliation state is not closed | Adjudicate legacy references and document retention/deletion decisions |
| P1 | Consent helper not wired as a universal hard gate | Processing may proceed without purpose-specific consent enforcement | Define purposes and call the gate before applicable analysis, extraction, research use, and export |
| P1 | Deployment security controls external/incomplete | TLS, disk encryption, MFA, shared rate limits, and secrets operations are not guaranteed by the repository | Complete deployment threat model and control implementation |
| P1 | In-process queue | Limits isolation, failover, throughput, and operational ownership | Add external workers/queueing, durable observability, and recovery runbooks |
| P2 | Dev audit advisory | Test tooling has a moderate path-traversal/arbitrary-read advisory | Upgrade Vitest in a controlled branch and rerun the full suite |
| P2 | DICOM/FHIR/interoperability incomplete | Limits clinical integration and safe metadata handling | Define supported standards and fail-closed behavior before integration |
| P2 | Historical documentation drift | Operators may follow obsolete phase-era instructions | Update or archive conflicting phase-era documents |
| P2 | Legacy visual QA script | Unauthenticated structural checks can give misleading coverage | Replace with authenticated visual/browser evidence |
| P3 | Empty medication registry | Treatment-support views cannot provide evidence-backed medication knowledge | Integrate and govern a citable source before enabling treatment evidence |

## 17. Recommended next actions

### Before any research distribution

1. Resolve the 235 active reconciliation blockers and make the release-data check green for the intended dataset.
2. Decide and document the disposition of the 5,263 legacy detached references and 75 legacy unresolved records.
3. Wire purpose-specific consent enforcement into every analysis, extraction, research, and export path where consent is required.
4. Upgrade Vitest after reviewing compatibility and rerun the full test/build/browser matrix.
5. Update the generated release inventory at the exact release commit and archive stale inventories.
6. Replace or repair the legacy visual QA script with authenticated evidence.
7. Run a release-time backup restore and record the result.

### Before any clinical consideration

1. Establish a formal intended use, target population, acquisition/device scope, and human oversight policy.
2. Conduct independent clinical validation for every proposed model/use combination.
3. Establish calibration, threshold governance, uncertainty/OOD performance, subgroup analysis, and failure-mode monitoring.
4. Keep diagnosis and treatment gates closed until the required evidence is accepted by the responsible governance process.
5. Complete TLS, encryption, secrets, MFA, shared rate limiting, audit retention, incident response, access review, and data-subject-rights workflows.
6. Add production worker isolation, monitoring, alerting, backup/restore drills, and a tested rollback plan.
7. Define DICOM/FHIR support, de-identification, device metadata, and interoperability boundaries.

### Documentation maintenance

The following existing documents contain historical statements that no longer match the current source and should be corrected or explicitly marked archival:

- docs/ARCHITECTURE.md
- docs/DATA_GOVERNANCE.md
- docs/PRODUCTION_READINESS.md
- docs/generated/release-inventory.json

In particular, the generated release inventory is timestamped 2026-09-11 and records source commit 69fcf4da5a1ee06f42c93eb793fa4ca2b5951bc3, while this report audits 3c702f2. Some phase documents still say that data/models/ is empty, although the current checkout contains three model artifacts. This is documentation drift, not a reason to weaken the safety gates.

## 18. Overall assessment

| Dimension | Assessment |
|---|---|
| Architecture | Strong research-platform foundation with clear module boundaries and provenance intent |
| Feature completeness | Broad workflow coverage across imaging, documents, evidence, reporting, review, and validation |
| Local engineering quality | Green on the fresh lint, typecheck, test, build, smoke, browser, model, and filesystem checks listed above |
| Safety posture | Thoughtful fail-closed controls and explicit non-clinical boundary; some governance gates remain unwired or external |
| Model readiness | Research-only; not clinically deployable |
| Data-release readiness | Not ready; active reconciliation blockers remain |
| Security/deployment readiness | Not independently production-ready; several controls depend on deployment infrastructure or remain absent |
| Clinical readiness | **No-go** |

### Final disposition

**Approve for continued local engineering and controlled research development.**  
**Do not approve for patient-facing clinical use, autonomous diagnosis, treatment recommendation, or unrestricted data release.**

## 19. Evidence index

- [Project README](../README.md)
- [Architecture](ARCHITECTURE.md)
- [Clinical safety rules](CLINICAL_SAFETY.md)
- [Authentication and RBAC](AUTH_RBAC.md)
- [Data governance](DATA_GOVERNANCE.md)
- [Production-readiness history](PRODUCTION_READINESS.md)
- [CI workflow](../.github/workflows/ci.yml)
- [Model manifests](../data/models/)
- [Generated release inventory](generated/release-inventory.json)
- [Generated SBOM](generated/SBOM.cdx.json)
- [Current full system report](VISIONSCAN_FULL_SYSTEM_REPORT_2026-09-12.md)

This report intentionally records both positive engineering evidence and unresolved safety/release findings. A green test suite is evidence about the tested software paths; it is not evidence of clinical validity or safe patient use.
